NewsBenzingaBiodexa Pharmaceuticals Enrolls 100 Patients In Its Registrational Phase 3 Serenta Trial Of eRapa In Familial Adenomatous Polyposis; Trial Is Recruiting At 29 Clinical Sites In U.S., Canada And Europe And Is Expected To Be Initiated Shortly Biodexa Pharmaceuticals Enrolls 100 Patients In Its Registrational Phase 3 Serenta Trial Of eRapa In Familial Adenomatous Polyposis; Trial Is Recruiting At 29 Clinical Sites In U.S., Canada And Europe And Is Expected To Be Initiated Shortly Benzinga 2026.10.13 12:34 (GMT+0) Open on Benzinga Other news Jensen Huang's GTC Berlin Keynote: NVIDIA Shifts from "Selling GPUs" to "Selling AI Factories," Vera Rubin Enters Full Production Anthropic releases new Claude API version, removing sampling parameters like temperature Tesla Doesn’t Sell a Single Bitcoin in Q3 as Crypto Stash Jumps 42% to $962 Million South Korea's IT and cybersecurity industry urgently responding to critical PHP vulnerability Ethereum spot ETFs saw $14.955 million in total net inflows yesterday, turning to net inflows after 5 consecutive days of net outflows Bitcoin spot ETFs saw $528 million in total net inflows yesterday, marking 3 consecutive days of net inflows
Jensen Huang's GTC Berlin Keynote: NVIDIA Shifts from "Selling GPUs" to "Selling AI Factories," Vera Rubin Enters Full Production
Ethereum spot ETFs saw $14.955 million in total net inflows yesterday, turning to net inflows after 5 consecutive days of net outflows
Bitcoin spot ETFs saw $528 million in total net inflows yesterday, marking 3 consecutive days of net inflows
